Journal article · 2017 · Open access

Adaptive Pathways Regulations for Stem Cells: Accelerating Access to Medicine or Deregulating Access to Markets?

Tsung-Ling Lee, Tamra Lysaght

SCRIPTed A Journal of Law Technology & Society, 14(1) · Published 20 June 2017 · DOI 10.2966/scrip.140117.81

Open PDFView at the publisherCite this paper

In brief

“Adaptive Pathways Regulations for Stem Cells: Accelerating Access to Medicine or Deregulating Access to Markets?” is a 2017 journal article by Tsung-Ling Lee and Tamra Lysaght, published in SCRIPTed A Journal of Law Technology & Society. OpenAlex counts 4 citations as of 19 November 2026, which puts it in the top 8% of works published in 2017 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at SCRIPTed A Journal of Law Technology & Society.

Citations
4
Most cited in
2018 (2)
Field-weighted impact
0.78
References
3
Authors
2

Abstract

In response to calls for faster access to innovative biomedicines, the European Medical Agency ran a two-year pilot program known as the “Adaptive Pathways” (AP) scheme. Under this approach, evidence is gathered and evaluated iteratively for license adaptation to reduce uncertainties rather than in an accumulative phased trial process. With the European Medicines Agency (EMA) aiming to mainstream the AP scheme, the regulatory approach of accelerating the approval process for novel biomedicines is in need of critical evaluation and should be viewed with some caution. Focusing on the recent market authorisation of a stem cell product, we scrutinise the legal and ethical merits of this programme. We draw attention to how the AP scheme will grant conditional marketing approval to medicinal products with limited clinical benefits. In response to the identified weaknesses of the AP scheme, we propose procedural safeguards which are in keeping with the EMA’s public health missions.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Lee, T.-L., & Lysaght, T. (2017). Adaptive Pathways Regulations for Stem Cells: Accelerating Access to Medicine or Deregulating Access to Markets? SCRIPTed A Journal of Law Technology & Society, 14(1). https://doi.org/10.2966/scrip.140117.81

MLA 9

Lee, Tsung-Ling, and Tamra Lysaght. “Adaptive Pathways Regulations for Stem Cells: Accelerating Access to Medicine or Deregulating Access to Markets?” SCRIPTed A Journal of Law Technology & Society, vol. 14, no. 1, 2017. https://doi.org/10.2966/scrip.140117.81.

Chicago

Lee, Tsung-Ling and Tamra Lysaght. 2017. “Adaptive Pathways Regulations for Stem Cells: Accelerating Access to Medicine or Deregulating Access to Markets?” SCRIPTed A Journal of Law Technology & Society 14 (1). https://doi.org/10.2966/scrip.140117.81.

Harvard

Lee, T.-L. and Lysaght, T. (2017) ‘Adaptive Pathways Regulations for Stem Cells: Accelerating Access to Medicine or Deregulating Access to Markets?’, SCRIPTed A Journal of Law Technology & Society, 14(1). doi:10.2966/scrip.140117.81.

IEEE

T.-L. Lee and T. Lysaght, “Adaptive Pathways Regulations for Stem Cells: Accelerating Access to Medicine or Deregulating Access to Markets?,” SCRIPTed A Journal of Law Technology & Society, vol. 14, no. 1, 2017, doi: 10.2966/scrip.140117.81.

BibTeX

@article{lee2017adaptive,
  title     = {{Adaptive Pathways Regulations for Stem Cells: Accelerating Access to Medicine or Deregulating Access to Markets?}},
  author    = {Lee, Tsung-Ling and Lysaght, Tamra},
  journal   = {SCRIPTed A Journal of Law Technology \& Society},
  year      = {2017},
  volume    = {14},
  number    = {1},
  doi       = {10.2966/scrip.140117.81},
  url       = {https://doi.org/10.2966/scrip.140117.81}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation

  • adaptive pathways
  • stem cell products
  • conditional marketing authorisation
  • drug regulation
  • European Medicines Agency
  • procedural guarantees
  • access to medicines

Work with this paper

Most-cited papers in Nursing

All highly cited Nursing papers

Questions about this paper

How do I cite this paper in APA style?

Lee, T.-L., & Lysaght, T. (2017). Adaptive Pathways Regulations for Stem Cells: Accelerating Access to Medicine or Deregulating Access to Markets? SCRIPTed A Journal of Law Technology & Society, 14(1). https://doi.org/10.2966/scrip.140117.81

How many times has this paper been cited?

4 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at SCRIPTed A Journal of Law Technology & Society: sign in and open the PDF from this page.

Who wrote this paper?

Tsung-Ling Lee, Tamra Lysaght.

What is the DOI of this paper?

10.2966/scrip.140117.81, permanently at https://doi.org/10.2966/scrip.140117.81. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.